CHRO
Chromocell Therapeutics Corporation Common Stock (CHRO)
$36
About Chromocell Therapeutics Corporation Common Stock (CHRO)
Channel Therapeutics Corp. is a clinical-stage biotech company that engages in the development and commercialization of new therapeutics to alleviate pain. The company was founded in 2002 and is headquartered in Freehold, NJ.
Details
Daily high
$1.36
Daily low
$1.26
Price at open
--
52 Week High
$3.80
52 Week Low
$0.45
Market cap
8.3M
Dividend yield
0.00%
Volume
525
Avg. volume
2.2M
P/E ratio
-.79
Chromocell Therapeutics Corporation Common Stock News
Details
Daily high
$1.36
Daily low
$1.26
Price at open
--
52 Week High
$3.80
52 Week Low
$0.45
Market cap
8.3M
Dividend yield
0.00%
Volume
525
Avg. volume
2.2M
P/E ratio
-.79